Jilong Yang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
- Vascular Tumors and Angiosarcomas
Papers in
-
- Sarcoma Diagnosis and Treatment 43
- Oncology 41
- CAR-T cell therapy research 13
- Vascular Tumors and Angiosarcomas 7
- Co-authors
- Wei ZhangKexin ChenXiaoling DuGuowen WangFengju SongChao ZhangXinyue LiuZhichao Liao
- Journals
- Chinese Journal of Cancer (6 papers)Frontiers in Oncology (6 papers)Journal of Clinical Oncology (5 papers)Cancer Biology and Medicine (5 papers)Blood (4 papers)
- Partner nations
- ChinaUnited StatesFinland
In The Last Decade
Jilong Yang
99 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 113
- Cancer Research 498
- Oncology 708
- Pulmonary and Respiratory Medicine 720
- Gastroenterology 97
- Molecular Biology 1.2k
Countries citing papers authored by Jilong Yang
This map shows the geographic impact of Jilong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jilong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jilong Yang more than expected).
Fields of papers citing papers by Jilong Yang
This network shows the impact of papers produced by Jilong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jilong Yang. The network helps show where Jilong Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jilong Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2021 | 9 | |
| 8 | 2020 | 6 | |
| 9 | 2020 | 1 | |
| 10 | 2020 | 41 | |
| 11 | 2019 | 2 | |
| 12 | 2019 | 14 | |
| 13 | 2015 | 48 | |
| 14 | 2014 | 30 | |
| 15 | 2013 | 1 | |
| 16 | 2012 | 3 | |
| 17 | The application of terahertz imaging in tumor diagnosis | 2012 | 1 |
| 18 | 2011 | 44 | |
| 19 | 2011 | 1 | |
| 20 | 2007 | 30 |
About Jilong Yang
Jilong Yang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Gastroenterology, Neurology and Molecular Biology, having authored 109 papers that have together received 2.3k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (43 papers), CAR-T cell therapy research (13 papers), Neurofibromatosis and Schwannoma Cases (10 papers), Melanoma and MAPK Pathways (8 papers), RNA modifications and cancer (8 papers), Gastrointestinal Tumor Research and Treatment (7 papers), Vascular Tumors and Angiosarcomas (7 papers) and Cancer-related gene regulation (7 papers). The work is most often cited by research in Cancer Research (498 citations), Oncology (708 citations), Pulmonary and Respiratory Medicine (720 citations), Gastroenterology (97 citations) and Molecular Biology (1.2k citations). Jilong Yang has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Wei Zhang, Kexin Chen, Xiaoling Du, Guowen Wang, Fengju Song, Chao Zhang, Xinyue Liu, Wei Zhang, Zhichao Liao and Jonathan C. Trent. Their work appears in journals such as Chinese Journal of Cancer, Frontiers in Oncology, Journal of Clinical Oncology, Cancer Biology and Medicine and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.